Last reviewed · How we verify
NCT04401228
Predictive Models for Intensive Care Admission and Death of COVID-19
trial testing predict admission of covid-19 patients to ICU and death with routine and quickly avalaible clinical, biological and radiological variables? in COVID19 in 60 participants. Status unknown.
1 May 2020
Quick facts
| Lead sponsor | Clinique Saint Pierre Ottignies |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 March 2020 |
| Primary completion | 1 May 2020 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- predict admission of covid-19 patients to ICU and death with routine and quickly avalaible clinical, biological and radiological variables?
Conditions studied
- COVID19 — all drugs for COVID19 →
- Pneumonia, Viral — all drugs for Pneumonia, Viral →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
Clinique Saint Pierre Ottignies — full company profile →
Who can join
18 and older, any sex, with COVID19 or Pneumonia, Viral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To build simple and reliable predictive scores for intensive care admissions and deaths in COVID19 patients. These scores adhere to the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) reporting guidelines. The outcomes of the study are (i) admission in the Intensive Care Unit admission and (ii) death. All patients admitted in the Emergency Department with a positive reverse transcription-polymerase chain reaction SARS-COV2 test were included in the study. Routine clinical and laboratory data were collected at their admission and during their stay. Chest X-Rays and CT-Scans were performed and analyzed by a senior radiologist. Generalized Linear Models using a binomial distribution with a logit link function (R software version X) were used to develop predictive scores for (i) admission to ICU among emergency ward patients; (ii) death among ICU patients. A first panel of Number Models with the highest AIC (BIC) was preselected. Ten-fold cross-validation was then used to estimate the out-of-sample prediction error among these preselected models. The one with the smallest prediction error was in the end singled out .
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Decoding mechanisms and protein markers in lung-brain axis.
Huang S, Zhou Y, Ji H, Zhang T, et al · · 2025 · cited 7× · PMID 40390067 · DOI 10.1186/s12931-025-03272-z
Verify or expand the search:
- PubMed search for NCT04401228
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID19
Currently open trials in the same condition.
- NCT07337382 — The Optimising Isolation, Quarantine and Distancing Study for COVID-19 · active not recruiting
- NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
- NCT04367883 — Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection · recruiting
Other Clinique Saint Pierre Ottignies trials
Trials by the same sponsor.
- NCT07384598 — Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure · NA · not yet recruiting
- NCT04403360 — Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery · NA · unknown
- NCT04982055 — Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04401228 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinique Saint Pierre Ottignies
- Last refreshed: 26 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04401228.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing